MED EQUUS LIMITEDActive

Company number 07389301Private limited companyIncorporated 2010
⚠ Confirmation statement overdue. It was due on 12 Oct 2026.

Key figures

£662,463-20.9%
Net assets 2024/25
+15.8%
Average annual growth 2019/20–2024/25
0250 k500 k750 k1 m2019/202020/212021/222022/232023/242024/25

Like most small UK companies, MED EQUUS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand263,880290,536181,596338,140234,841
Total assets615,842596,071575,588841,337648,888
Total liabilities287,135233,745362,880422,206379,744
Net assets / total equity498,358508,007552,081837,938662,463
Average number of employees911111013

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: MED EQUUS LIMITED

Company

MED EQUUS LIMITED is a private limited company registered with Companies House under company number 07389301. It was incorporated on 28 Sep 2010. Its status is active. The registered office is in Oswestry (SY11). Its nature of business (SIC 2007) is veterinary activities (75000).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files abridged accounts (unaudited). Net assets were £662,463, down 20.9% on the previous year. Cash at bank and in hand was £234,841. Total assets were £648,888 and total liabilities £379,744. The company had an average of 13 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 12 Oct 2026.